Physician
Alvaro J. Dangond, Md,pa.
Alvaro J. Dangond, Md,pa. was paid $3.69M by Medicaid between Dec 2018 and Sep 2024, across 59 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 58% of everything it billed.
33Billing provider infoALVARO J. DANGOND, MD,PA.
MIAMI, FL 33173
MIAMI, FL 33173
33aNPI1447327697assigned 11/30/2006
33bProvider typePediatrics Physician
28Total paid$3.69M
24GClaims116,463
24DCodes billed59
24AFirst – last monthDec 2018 – Sep 2024
Compared with peers
Next to other Pediatrics Physician providers in Florida
Rank by total paid#88 of 971
Median peer was paid$238K
This provider vs. median15×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,397 | $36K | |
| 2019 | 20,145 | $585K | |
| 2020 | 19,205 | $534K | |
| 2021 | 20,041 | $670K | |
| 2022 | 20,850 | $683K | |
| 2023 | 23,172 | $736K | |
| 2024incomplete | 11,653 | $446K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 58% | 40,883 | 34,039 | $2.14M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 12% | 4,290 | 4,173 | $459K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 7.9% | 2,981 | 2,790 | $293K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.8% | 2,824 | 2,671 | $289K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.1% | 1,586 | 1,505 | $152K |
| 90670 | 1.9% | 1,999 | 1,939 | $69K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.3% | 10,166 | 9,546 | $49K |
| 90716 | 1.2% | 1,067 | 1,037 | $43K | |
| 92552 | <1% | 6,365 | 6,006 | $35K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 485 | 478 | $33K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 2,899 | 2,769 | $21K |
| 90651 | <1% | 606 | 580 | $18K |
47 more codes
| 90461 | <1% | 4,112 | $17K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 5,767 | $12K |
| 90698 | <1% | 1,042 | $7K | |
| 87400 | <1% | 665 | $5K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 543 | $4K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,064 | $4K |
| 90680 | <1% | 1,216 | $4K | |
| 90620 | <1% | 56 | $4K | |
| 99173 | <1% | 8,131 | $3K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 73 | $3K |
| 90619 | <1% | 106 | $2K | |
| 90697 | <1% | 108 | $2K | |
| 0071A | <1% | 66 | $2K | |
| 90633 | <1% | 1,091 | $2K | |
| 0072A | <1% | 54 | $2K | |
| 87081 | <1% | 1,986 | $2K | |
| 90686 | <1% | 1,386 | $1K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 16 | $1K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 511 | $878.37 |
| 90707 | <1% | 1,031 | $859.56 | |
| 99058 | <1% | 1,127 | $686.22 | |
| 90734 | <1% | 191 | $681.62 | |
| 99441 | <1% | 1,258 | $673.99 | |
| 90744 | <1% | 822 | $552.89 | |
| 90700 | <1% | 733 | $546.38 | |
| 87430 | <1% | 45 | $253.25 | |
| 99051 | <1% | 558 | $230.37 | |
| 90713 | <1% | 195 | $178.01 | |
| 94664 | <1% | 153 | $147.59 | |
| A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | <1% | 140 | $108.45 |
| 36416 | <1% | 1,184 | $101.29 | |
| 90688 | <1% | 273 | $96.82 | |
| 81000 | <1% | 429 | $83.21 | |
| 90715 | <1% | 54 | $82.78 | |
| 90687 | <1% | 303 | $33.25 | |
| Q3014 | Telehealth originating site facility fee | <1% | 44 | $25.64 |
| 90648 | <1% | 190 | $25.25 | |
| 99050 | <1% | 110 | $22.85 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 158 | $21.40 |
| H0049 | Alcohol and/or drug screening | <1% | 12 | $17.08 |
| 90696 | <1% | 58 | $10.00 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 31 | $1.65 |
| A7015 | Aerosol mask, used with dme nebulizer | 0% | 128 | $0.00 |
| 90677 | 0% | 32 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 19 | $0.00 |
| 90662 | 0% | 29 | $0.00 | |
| 90621 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDANGOND, ALVARO (PRESIDENT)